Azenta (NASDAQ:AZTA) Stock Price Expected to Rise, Needham & Company LLC Analyst Says

Azenta (NASDAQ:AZTA) had its target price increased by Needham & Company LLC from $37.00 to $57.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC‘s price objective suggests a potential upside of 16.56% from the stock’s current price.

Several other brokerages have also issued reports on AZTA. Jefferies Financial Group boosted their target price on Azenta from $44.00 to $52.00 and gave the company a “buy” rating in a research report on Wednesday. Wall Street Zen downgraded Azenta from a “buy” rating to a “hold” rating in a report on Sunday, October 18th. Finally, Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $47.60.

Azenta Trading Up 20.8%

Azenta stock opened at $48.90 on Wednesday. Azenta has a 12-month low of $15.93 and a 12-month high of $50.06. The firm has a 50-day moving average price of $35.98 and a 200-day moving average price of $28.51. The firm has a market capitalization of $2.14 billion, a PE ratio of -13.51 and a beta of 1.47.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Tuesday, November 10th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.11 by $0.17. Azenta had a negative net margin of 26.86% and a positive return on equity of 1.37%. The company had revenue of $167.09 million for the quarter, compared to the consensus estimate of $160.16 million.

Institutional Investors Weigh In On Azenta

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. GW&K Investment Management LLC grew its stake in Azenta by 0.4% in the third quarter. GW&K Investment Management LLC now owns 992,616 shares of the company’s stock worth $34,633,000 after purchasing an additional 4,187 shares in the last quarter. Boston Partners increased its position in Azenta by 22.6% during the 3rd quarter. Boston Partners now owns 11,996 shares of the company’s stock valued at $419,000 after purchasing an additional 2,215 shares during the period. Voya Investment Management LLC raised its holdings in shares of Azenta by 56.9% in the 3rd quarter. Voya Investment Management LLC now owns 26,341 shares of the company’s stock valued at $919,000 after purchasing an additional 9,549 shares in the last quarter. Global Retirement Partners LLC lifted its position in shares of Azenta by 82.3% in the 3rd quarter. Global Retirement Partners LLC now owns 771 shares of the company’s stock worth $27,000 after purchasing an additional 348 shares during the period. Finally, Edgestream Partners L.P. purchased a new stake in shares of Azenta in the 3rd quarter worth approximately $9,489,000. Institutional investors own 99.08% of the company’s stock.

Latest Azenta News

These are some of the AZTA news items that stood out recently:

• Positive Sentiment: Better FY2027 outlook: The company forecast revenue of $648 million to $660 million, above the $632.4 million consensus, with organic growth of 3%–5% after 2% in FY2026. It also expects adjusted EBITDA margin to expand by roughly 200–250 basis points, signaling improving business momentum. Azenta FY2026 results and FY2027 outlook
• Positive Sentiment: Buyback support: Azenta repurchased 4.4 million shares for $118.2 million in FY2026 and ended the year with $506 million in cash and marketable securities, providing financial flexibility and supporting per-share value. Azenta share repurchases and outlook
• Negative Sentiment: Legal overhang: Rosen Law Firm announced an investigation into possible securities claims alleging Azenta may have provided materially misleading business information. The claims are allegations, not findings, but could add uncertainty for investors. Securities class action investigation announcement

About Azenta

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.